Publications
-
Participant Perspectives and Experiences Following an Intensively Monitored Antiretroviral Pause in
Citation: Karine Dubé, Shadi Eskaf, Liz Barr, David Palm, Evelyn Hogg, Jane M. Simoni, Jeremy Sugarman, Brandon Brown, John A. Sauceda, Laney Henley, Steven Deeks, Lawrence Fox, Rajesh T. Gandhi, Davey Smith, and Jonathan Z. Li.AIDS Research and Human Retroviruses.ahead of printhttp://doi.org/10.1089/aid.2021.0170
Date: 05/03/2022
Regional Differences in Risk of Recurrent Falls Among Older U.S. Women and Men with HIV in the HIV
Citation: Mona Abdo, Xingye Wu, Anjali Sharma, Katherine K. Tassiopoulos, Todd T. Brown, Susan L. Koletar, Michael T. Yin, Kristine M. Erlandson, and the ACTG A5322 Study Team.AIDS Research and Human Retroviruses.ahead of printhttp://doi.org/10.1089/aid.2021.0162
Date: 05/03/2022
A randomized clinical trial of HPV test-and-treat as compared to cytology-based screening for
Citation: Timothy Wilkin, Huichao Chen, Vikrant Sahasrabuddhe, Roy Matining, Rosie Mngqibisa, Lameck Chinula, Yamikani Mbilizi, Tsitsi Magure, Ayotunde E Omoz-Oarhe, Mohammed Rassool, Cynthia Riviere, Rhamesh Bhosale, Sheela Godbole, Reena Naranjo, Robert Coombs, Pamela Michelow, Catherine Godfrey, Cynthia Firnhaber, A randomized clinical trial of HPV test-and-treat as compared to cytology-based screening for prevention of cervical cancer among women living with HIV: AIDS Clinical Trials Group Protocol A5282, Clinical Infectious Diseases, 2022;, ciac213, https://doi.org/10.1093/cid/ciac213
Date: 05/03/2022
The impact of short term Antiretroviral Therapy (ART) interruptions on longer term maternal health
Citation: Atuhaire P, S Brummel S, Mmbaga BT, Angelidou K, Fairlie L, Violari A, Theron G, Mukuzunga C, Mawlana S, Mubiana-Mbewe M, Naidoo M, Makanani B, Mandima P, Nematadzira T, Suryavanshi N, Mbengeranwa T, Loftis A, Basar M, McCarthy K, Currier JS, Fowler MG; 1077BF/1077FF PROMISE Team. The impact of short term Antiretroviral Therapy (ART) interruptions on longer term maternal health outcomes-A randomized clinical trial. PLoS One. 2020 Jan 30;15(1):e0228003. doi: 10.1371/journal.pone.0228003. PMID: 31999753; PMCID: PMC6992010.
Date: 07/13/2021
Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine
Citation: Haas DW, Podany AT, Bao Y, Swindells S, Chaisson RE, Mwelase N, Supparatpinyo K, Mohapi L, Gupta A, Benson CA, Baker P, Fletcher CV. Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine. Pharmacogenet Genomics. 2021 Jan;31(1):17-27. doi: 10.1097/FPC.0000000000000417. PMID: 32815870; PMCID: PMC7655626.
Date: 01/15/2021
Validation of NINA-DISH food frequency questionnaire with multiple 24-hour dietary recalls among
Citation: Rajagopalan K, Alexander M, Naik S, Patil N, Mehta S, Leu CS, Bhosale R, Mathad J, Caulfield LE, Gupta A, Talegawkar SA, Shivakoti R. Validation of NINA-DISH food frequency questionnaire with multiple 24-hour dietary recalls among pregnant women in Pune, India. Br J Nutr. 2020 Dec 28:1-28. doi: 10.1017/S0007114520005188. Epub ahead of print. PMID: 33357249.
Date: 01/06/2021
Association of Vegetable and Animal Flesh Intake with Inflammation in Pregnant Women from India
Citation: Yadana, S.; Talegawkar, S.A.; Mathad, J.S.; Alexander, M.; Rajagopalan, K.; Kumar, P.; Naik, S.; Leu, C.-S.; Kulkarni, V.; Deshpande, P.; Araujo-Pereira, M.; Bhosale, R.; Babu, S.; Andrade, B.B.; Caulfield, L.E.; Gupta, A.; Shivakoti, R. Association of Vegetable and Animal Flesh Intake with Inflammation in Pregnant Women from India. Nutrients 2020, 12, 3767.
Date: 12/08/2020
Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB
Citation: Podany AT, Leon-Cruz J, Hakim J, Supparatpinyo K, Omoz-Oarhe A, Langat D, Mwelase N, Kanyama C, Gupta A, Benson CA, Chaisson RE, Swindells S, Fletcher CV; AIDS Clinical Trials Group A5279 Team. Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention. J Antimicrob Chemother. 2020 Nov 26:dkaa470. doi: 10.1093/jac/dkaa470. Epub ahead of print. PMID: 33241266.
Date: 11/26/2020
Using a composite maternal-infant outcome measure in tuberculosis prevention studies among pregnant
Citation: Montepiedra G, Kim S, Weinberg A, Theron G, Sterling TR, LaCourse SM, Bradford S, Chakhtoura N, Jean-Philippe P, Evans S, Gupta A. Using a composite maternal-infant outcome measure in tuberculosis prevention studies among pregnant women. Clin Infect Dis. 2020 Nov 4:ciaa1674. doi: 10.1093/cid/ciaa1674. Epub ahead of print. PMID: 33146706.
Date: 11/04/2020
Pharmacokinetics and drug-drug interactions of isoniazid and efavirenz in pregnant women living with
Citation: Gausi K, Wiesner L, Norman J, Wallis CL, Onyango-Makumbi C, Chipato T, Haas DW, Browning R, Chakhtoura N, Montepiedra G, Aaron L, McCarthy K, Bradford S, Vhembo T, Stranix-Chibanda L, Masheto GR, Violari A, Mmbaga BT, Aurpibul L, Bhosale R, Nevrekhar N, Rouzier V, Kabugho E, Mutambanengwe M, Chanaiwa V, Nyati M, Mhembere T, Tongprasert F, Hesseling A, Shin K, Zimmer B, Costello D, Jean-Philippe P, Sterling TR, Theron G, Weinberg A, Gupta A, Denti P; IMPAACT P1078 (TB APPRISE) Study Group Team. Pharmacokinetics and drug-drug interactions of isoniazid and efavirenz in pregnant women living with HIV in high TB incidence settings: importance of genotyping. Clin Pharmacol Ther. 2020 Sep 9. doi: 10.1002/cpt.2044. Epub ahead of print. PMID: 32909316.
Date: 09/09/2020
- 1 2 3 > Last ›